EFG Asset Management (Americas)’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-10,774
Closed -$2.21M 142
2017
Q3
$2.21M Buy
10,774
+354
+3% +$82.3K 0.84% 40
2017
Q2
$2.56M Buy
10,420
+2,276
+28% +$535K 0.97% 27
2017
Q1
$1.98M Sell
8,144
-1,895
-19% -$441K 0.76% 41
2016
Q4
$2.14M Sell
10,039
-10,692
-52% -$2.21M 0.93% 35
2016
Q3
$4.8M Sell
20,731
-953
-4% -$233K 2.03% 8
2016
Q2
$5.04M Buy
21,684
+7,285
+51% +$1.68M 2.37% 8
2016
Q1
$3.86M Buy
14,399
+2,643
+22% +$757K 1.93% 14
2015
Q4
$3.35M Buy
11,756
+2,905
+33% +$865K 2.08% 10
2015
Q3
$2.41M Buy
+8,851
New +$2.72M 1.5% 15

Other funds holding AGN

EFG Asset Management (Americas)'s AGN Position: Q4 2017 in Review

EFG Asset Management (Americas) sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 10,774 shares — an estimated $2.21M sold.

EFG Asset Management (Americas) first reported a position in AGN in Q3 2015 and held it in 9 quarters. The position peaked at $5.04M in Q2 2016. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • EFG Asset Management (Americas) reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • EFG Asset Management (Americas) sold 10,774 Allergan plc shares in Q4 2017, an estimated $2.21M.
  • EFG Asset Management (Americas) first reported a position in Allergan plc in Q3 2015 and held it in 9 quarters.
  • EFG Asset Management (Americas)'s Allergan plc position peaked at $5.04M in Q2 2016.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on EFG Asset Management (Americas)'s 13F filing for Q4 2017, filed 7 Feb 2018.